Astrazeneca
-
GenXZeneca Trend: GenXers Rush to Vaccination Sites After Becoming Eligible for AstraZeneca Vaccine
-
AstraZeneca Updated Data: From 79% Down to 76% Efficacy Rate, Still 100% Effective for Severe Cases, Said Company
-
[UPDATE] AstraZeneca 'Cherry-Picking' Data Vaccine Issue Worse Than Anyone Can Imagine
-
AstraZeneca Vaccine, Blood Clot Link Unveiled by European Experts - Is Vaccine Still Safe for Those Who Have Blood Clot History?
-
US Health Officials Question AstraZeneca's COVID-19 Vaccination Data, Says it is Outdated
-
Europe’s AstraZeneca Vaccine Suspension Could Have Far-Reaching Consequences
-
New COVID-19 Vaccine Trial Will Combine Different Vaccines for the First Time
-
COVID-19 AstraZeneca Vaccine Shots Drastically Reduce Viral Transmission, Will It Finally End the Pandemic?
-
COVID-19 Vaccine Trials: US Kids Reportedly Sign Up for Pfizer, Moderna, and AstraZeneca Tests
-
Suspension of Astrazeneca's COVID-19 Vaccine Trial in US Continues As FDA Probes Serious Spinal Cord Side Effect Despite UK's Resume
-
COVID-19 Vaccine Update: AstraZeneca Chief Says Oxford Vaccine Might Still Be Released This Year
-
AstraZeneca Suspended Human Trials After Reports of Serious Side Effects Including Transverse Myelitis
Most Popular
